D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.2B |
| 2 |
NVIDIA
NVDA
|
+$1.02B |
| 3 |
T-Mobile US
TMUS
|
+$911M |
| 4 |
Netflix
NFLX
|
+$699M |
| 5 |
Micron Technology
MU
|
+$672M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$768M |
| 2 |
Robinhood
HOOD
|
+$643M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$534M |
| 4 |
Microsoft
MSFT
|
+$493M |
| 5 |
Intuit
INTU
|
+$472M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.33% |
| 2 | Healthcare | 8.66% |
| 3 | Consumer Discretionary | 8.33% |
| 4 | Financials | 6.44% |
| 5 | Industrials | 6.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3601
Jazz Pharmaceuticals
JAZZ
$15.9B
| $415K | ﹤0.01% |
3,906
-62,285
| -94% | -$6.77M |
|
3602
A10 Networks
ATEN
$2.47B
| $413K | ﹤0.01% |
+21,340
| New | +$365K |
|
3603
CALL
Edison International
EIX
$30.7B
| $413K | ﹤0.01% |
8,000
-56,700
| -88% | -$3.11M |
|
3604
Village Super Market
VLGEA
$631M
| $413K | ﹤0.01% |
10,715
+2,205
| +26% | +$81.4K |
|
3605
Ooma
OOMA
$550M
| $412K | ﹤0.01% |
31,957
-14,263
| -31% | -$181K |
|
3606
DXP Enterprises
DXPE
$2.62B
| $412K | ﹤0.01% |
4,695
+1,100
| +31% | +$91.6K |
|
3607
PUT
3D Systems Corp
DDD
$420M
| $411K | ﹤0.01% |
267,000
| – | – |
|
3608
Entegris
ENTG
$19.7B
| $410K | ﹤0.01% |
+5,080
| New | +$386K |
|
|
TIGR
3609
PUT
UP Fintech Holding
TIGR
$845M
| $409K | ﹤0.01% |
+42,400
| New | +$354K |
|
|
PKST
3610
DELISTED
Peakstone Realty Trust
PKST
| $409K | ﹤0.01% |
30,924
-17,792
| -37% | -$219K |
|
3611
NorthWestern Energy
NWE
$4.48B
| $408K | ﹤0.01% |
+7,950
| New | +$439K |
|
3612
CALL
HF Sinclair
DINO
$15.9B
| $407K | ﹤0.01% |
9,900
-1,900
| -16% | -$65.4K |
|
3613
Vanguard Mid-Cap Growth ETF
VOT
$19B
| $405K | ﹤0.01% |
1,424
| – | – |
|
3614
Vera Bradley
VRA
$105M
| $405K | ﹤0.01% |
183,138
-60,344
| -25% | -$124K |
|
3615
Barrett Business Services
BBSI
$976M
| $404K | ﹤0.01% |
+9,687
| New | +$398K |
|
3616
Noble Corp
NE
$6.9B
| $402K | ﹤0.01% |
+15,131
| New | +$363K |
|
3617
Equity Bancshares
EQBK
$1.03B
| $402K | ﹤0.01% |
9,846
-4,854
| -33% | -$188K |
|
3618
Montauk Renewables
MNTK
$266M
| $401K | ﹤0.01% |
180,483
-9,869
| -5% | -$20.9K |
|
3619
International General Insurance
IGIC
$1.23B
| $401K | ﹤0.01% |
+16,679
| New | +$396K |
|
3620
Waters Corp
WAT
$36.8B
| $399K | ﹤0.01% |
1,143
-2,411
| -68% | -$829K |
|
3621
Ubiquiti
UI
$31.8B
| $398K | ﹤0.01% |
968
| – | – |
|
3622
CALL
Align Technology
ALGN
$12B
| $398K | ﹤0.01% |
2,100
-100
| -5% | -$17.7K |
|
|
ZYXI
3623
DELISTED
Zynex
ZYXI
| $393K | ﹤0.01% |
152,372
+6,165
| +4% | +$13.9K |
|
|
APLS
3624
PUT
DELISTED
Apellis Pharmaceuticals
APLS
| $393K | ﹤0.01% |
22,700
-15,400
| -40% | -$285K |
|
3625
Revolution Medicines Inc Warrant
RVMDW
$105M
| $393K | ﹤0.01% |
1,454,895
| – | – |
|
Similar funds
D.E. Shaw & Co's Q2 2025 Portfolio in Review
As of Q2 2025, D.E. Shaw & Co held 4,838 positions worth $141B, up 26% from $112B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
D.E. Shaw & Co deployed $7.51B of net new capital in Q2 2025, opening 647 new positions and adding to 1,556 existing holdings. Its largest new stake was Sea Limited: 1,365,221 shares worth $218M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was GE Vernova, an estimated $768M trimmed.
- D.E. Shaw & Co's largest Q2 2025 buy was Sea Limited: 1,365,221 shares worth $218M.
- D.E. Shaw & Co added most to Apple in Q2 2025, an estimated $1.2B increase.
- D.E. Shaw & Co's biggest Q2 2025 reduction was GE Vernova, cutting an estimated $768M.
- D.E. Shaw & Co fully exited Novo Nordisk in Q2 2025, selling an estimated $176M.
- D.E. Shaw & Co's ten largest holdings make up 12% of its $141B portfolio in Q2 2025.
- D.E. Shaw & Co opened 647 new positions and closed 532 in Q2 2025.
- D.E. Shaw & Co's portfolio value rose 26% quarter-over-quarter to $141B.
Based on D.E. Shaw & Co's 13F filing for Q2 2025, filed 14 Aug 2025.